| Unique ID issued by UMIN | UMIN000063673 |
|---|---|
| Receipt number | R000070014 |
| Scientific Title | Effects of Exercise Interventions in Individuals With Substance Use Disorders: A Systematic Review |
| Date of disclosure of the study information | 2026/11/18 |
| Last modified on | 2026/11/18 10:51:09 |
The effects of exercise intervention on drug addicts: A systematic review
EXERDA-SR
Effects of Exercise Interventions in Individuals With Substance Use Disorders: A Systematic Review
EXSUD-SR
| Japan | Asia(except Japan) | North America |
| Australia | Europe | Africa |
Substance Use Disorders
| Psychiatry | Rehabilitation medicine | Nursing |
Others
NO
This study aims to clarify the effects of exercise intervention on drug cravings and psychiatric symptoms in individuals with drug addiction.
Efficacy
Drug use, frequency of use, relapse rate, craving, depression, anxiety, quality of life, sleep, self-efficacy, impulsivity, executive function
Others,meta-analysis etc
| 18 | years-old | <= |
| Not applicable |
Male and Female
1.Studies involving adults aged 18 years or older diagnosed with drug use disorders involving substances other than alcohol and tobacco (nicotine), including over-the-counter medications, prescription medications, and illicit drugs.
2.Studies evaluating exercise interventions involving bodily movement, including aerobic exercise, resistance training, yoga, sports, and exercise therapy.
3.Studies with a comparator group receiving usual care, care without an exercise intervention, or wait-list control.
4.Studies assessing at least one of the following outcomes: drug craving, depression, anxiety, or quality of life (QOL).
5.Randomized controlled trials (RCTs).
6.Original research articles published in English or Japanese.
1.Studies exclusively involving alcohol use disorder or tobacco (nicotine) use disorder.
2.Studies exclusively involving participants younger than 18 years.
3.Studies without a clearly described exercise intervention.
4.Studies without a comparator group.
5.Studies not assessing any of the following outcomes: drug craving, depression, anxiety, or quality of life.
6.Studies other than randomized controlled trials.
7.Reviews, case reports, conference abstracts, conference proceedings, and study protocols.
8.Studies published in languages other than English or Japanese.
| 1st name | yuto |
| Middle name | |
| Last name | onodera |
Shonan University of Medical Sciences
Department of Nursing,Faculty of Health and Medical Sciences
2440806
16-48 Kamishinano, Totsuka-ku, Yokohama, Kanagawa
08047327306
yuto.tokyo70@gmail.com
| 1st name | yuto |
| Middle name | |
| Last name | onodera |
Shonan University of Medical Sciences
Department of Nursing,Faculty of Health and Medical Sciences
2440806
16-48 Kamishinano, Totsuka-ku, Yokohama, Kanagawa
08047327306
yuto.tokyo70@gmail.com
Shonan University of Medical Sciences
YutoOnodera
Japan Society for the Promotion of Science
Other
Not applicable (systematic review and meta-analysis)
Not applicable
N/A
N/A
NO
| 2026 | Year | 11 | Month | 18 | Day |
Unpublished
48
No longer recruiting
| 2025 | Year | 09 | Month | 13 | Day |
| 2025 | Year | 09 | Month | 13 | Day |
| 2026 | Year | 11 | Month | 18 | Day |
| 2027 | Year | 03 | Month | 31 | Day |
| 2027 | Year | 05 | Month | 31 | Day |
The primary outcome is drug craving, and the secondary outcomes are depression, anxiety, and quality of life (QOL). Meta-analysis will be conducted when quantitative synthesis is considered appropriate based on the clinical and methodological comparability of the included studies. Otherwise, a narrative synthesis will be performed.
| 2026 | Year | 11 | Month | 18 | Day |
| 2026 | Year | 11 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070014